Screening
Screening
Most of the cancers are curable when it is local and in primary stages. However, detecting a cancer while it is a few millimeters is a challenge for modern oncology. We provide noninvasive genetic tools for you to asses the risk and diagnose the disease as soon as possible.
Through the use of cutting-edge genetic technologies, our noninvasive diagnostic tools are designed to help individuals assess their cancer risk at an early stage when it is still localized and treatable. By detecting cancerous cells
while they are still in their primary stages, we aim to provide a more favorable prognosis and improve overall patient outcomes. Our innovative approach combines advanced genetic analysis with early detection strategies to empower individuals to take an active role in managing their cancer risk.
Breast Cancer Risk Assessment
You can get the detailed information about biomarkers, technology and material by clicking the Test information button.
4-6 weeks
Colorectal Cancer Risk Assessment
You can get the detailed information about biomarkers, technology and material by clicking the Test information button.
Order Test
4-6 weeks
Cervical Cancer Risk Assessment
You can get the detailed information about biomarkers, technology and material by clicking the Test information button.
Order Test
1 week
Prostate Cancer Risk Assessment
You can get the detailed information about biomarkers, technology and material by clicking the Test information button.
Order Test
4-6 weeks